“CONSEQUENCES OBSERVED WHEN MEROPENEM IS ADMINISTERED TO PATIENTS WITH COVID-19”, ECZ, pp. 34–35, Mar. 2024, Accessed: Sep. 14, 2025. [Online]. Available: https://econferencezone.org/index.php/ecz/article/view/2743